Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000827871-20-000028
Filing Date
2020-11-02
Accepted
2020-11-02 17:22:18
Documents
70
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q egrx-20200930.htm   iXBRL 10-Q 1545694
2 EX-10.1 exhibit101to3q202010-q.htm EX-10.1 58036
3 EX-31.1 exhibit311q32020.htm EX-31.1 8484
4 EX-31.2 exhibit312q32020.htm EX-31.2 8443
5 EX-32.1 exhibit321q32020.htm EX-32.1 9024
11 image_11.jpg GRAPHIC 2952
  Complete submission text file 0000827871-20-000028.txt   7106111

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT egrx-20200930.xsd EX-101.SCH 40292
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT egrx-20200930_cal.xml EX-101.CAL 113531
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT egrx-20200930_def.xml EX-101.DEF 161598
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT egrx-20200930_lab.xml EX-101.LAB 561808
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT egrx-20200930_pre.xml EX-101.PRE 346635
12 EXTRACTED XBRL INSTANCE DOCUMENT egrx-20200930_htm.xml XML 1317737
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36306 | Film No.: 201281346
SIC: 2834 Pharmaceutical Preparations